This article refers to this 309-page PDF consisting of communications acquired from the National Institutes of Health (NIH) with a Freedom of Information Act (FOIA) request:
https://childrenshealthdefense.org/wp-content/uploads/NIH-FOIA-59265-06.21.2024-Production.pdf
For further details, see the Background provided below.
"As early as January 2022, National Institutes of Health (NIH) researchers were aware of at least 850 peer-reviewed case reports and/or research articles about COVID-19 vaccine reactions, according to emails obtained by Children’s Health Defense (CHD).
In one email (name and agency redacted), NIH researchers were told the federal government was 'saddled' with the 'mess' of dealing with those injured by the COVID-19 vaccines, due to the liability shield enjoyed by vaccine manufacturers.
The emails, part of a 309-page batch of documents released to CHD on June 21, originated from a U.S. Food and Drug Administration (FDA) request to NIH researchers for input on a report highlighting several injuries common among people who received the vaccines...
The batch of documents released in June — which include emails to Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research — revealed that by fall 2021, key NIH researchers were aware of scientific studies on serious adverse events, including persistent neurological symptoms, following COVID-19 vaccines.
As with prior releases of the NIH documents, June’s tranche also included several emails from vaccine-injured individuals to NIH researchers, seeking help for their symptoms — with one person asking, 'Why aren’t you studying vaccine injuries?'
‘Tinnitus … was a freight train in my head for the first four months’
On Jan. 10, 2022, NIH researcher Dr. Avindra Nath was forwarded an email from someone whose name is redacted, with the subject line: 'Followup [sic] Jan 4th Meeting' (pages 281-289).
The original email, dated Jan. 9, 2022, was sent to FDA officials including Marks and Dr. Janet Woodcock, principal deputy commissioner of food and drugs, who apparently participated in a meeting on this topic on Jan. 4, 2022.
The Jan. 9, 2022 email included a list of 'persistent symptoms following the Covid vaccines' and the names of researchers who were studying these conditions, which included dysautonomia, neuropathy, tinnitus, multisystem inflammatory syndrome (MIS), myocarditis, blood clots and parasthesias.
The email was accompanied by a spreadsheet listing approximately 850 'peer-reviewed case reports/research articles about Covid vaccine reactions'...
[T]he email suggested 'it would be reasonable to approach autonomic specialists / long covid specialists about their observations'...
The email’s author also noted that, 'in my case yes, I have tinnitus now and it was a freight train in my head for the first four months.'
‘Is it reasonable to dismiss … 20 new symptoms … in a single person post vaccine?’
According to the email, myocarditis and blood clots were already 'acknowledged by the FDA and CDC' (Centers for Disease Control and Prevention).
'Every person in our groups that have one of these two conditions, also have accompanying neuro issues like those of us who are not currently acknowledged by the FDA and CDC,' the email said...
The email openly questioned why more wasn’t being done to connect these conditions in the vaccinated, to the COVID-19 vaccines themselves, noting that vaccinated people were frequently demonstrating multiple rare symptoms:
'While we understand that correlation does not equal causation, we also find a strong correlation with the change in our blood that mirrors long-haul, and symptomology that mirrors long-haul...
[W]hile it may be coincidental to have one or maybe two strange symptoms pop up, is it reasonable to dismiss 10, 15, 20 new symptoms that occur in a single person post vaccine.'
‘Insanely challenging for these people suffering … to walk this path alone’
... The author also asked Nath if he knew researchers 'who could fill in the gaps' and asked him if he would 'kindly be willing to discuss with Peter Marks?'
'The gov has conveniently absolved the drug companies of any liability, and the federal government is now saddled with the responsibility of figuring out this mess,' the email continued. “I am happy to orchestrate a meeting of the minds with NDR [non-disclosure] agreements if that would get the discussion started in a way that is similar to how previous new diseases have been investigated.'
The email also noted talks with public health officials in Germany and France.
'It has been insanely challenging for these people suffering to have to walk this path alone. They grow more and more desperate by the day. Knowing there is someone, somewhere looking into this makes a big difference for these people to just hang on.'
Even though public health agencies were aware of this information and were discussing vaccine injuries in early 2022, official government advice to the public continued to claim the COVID-19 vaccines were 'safe and effective,' including statements by Dr. Anthony Fauci in November 2022...
NIH researchers aware of vaccine injury studies in fall of 2021
... In a Sept. 2, 2021, email (pages 109-121), Farinaz Safavi, M.D., Ph.D., of the NIH Division of Neuroimmunology and Neurovirology was sent the results of the 'Covid Vaccine Persistent Symptoms Survey' conducted by React19, a group advocating on behalf of COVID-19 vaccine injury victims...
The most commonly reported symptoms included paresthesia, tinnitus, heart palpitations, tachycardia, chest pain, visual disturbance or loss, muscle twitching, joint pain, muscle aches, brain fog, fatigue and anxiety attacks...
Almost all respondents said these symptoms began less than two weeks following vaccination.
In a Nov. 15, 2021, email (pages 300-305), Nath was sent a scientific paper, 'Neurological side effects of SARS-CoV-2 vaccinations,' authored by Austrian researcher Josef Finsterer, M.D., Ph.D.
According to this paper, 'The most frequent neurological side effects of SARS-CoV-2 vaccines are headache,' Guillain-Barré syndrome, venous sinus thrombosis and transverse myelitis...
'Safety concerns against SARS-CoV-2 vaccines are backed by an increasing number of studies reporting neurological side effects'...
Nath received a review copy of this paper, which has since been published in Acta Neurologica Scandinavica...
In an email chain to Nath beginning Sept. 20, 2021, (pages 228-233) with the subject 'Paralyzed after J&J Covid Vaccine,' the author (whose name is redacted) said that less than 24 hours following vaccination, the patient 'lost bladder control.' He later developed a blood clot and erectile dysfunction, before becoming paralyzed.
In a response that day, Nath told the patient, 'The temporal association of the symptoms with the vaccine does make is [sic] suspect, but I do not know of any way how to sort it out.'"
Background:
On November 10, 2022, Children’s Health Defense (CHD) filed a Freedom of Information Act (FOIA) request for documents related to correspondence between National Institutes of Health (NIH) researchers and individuals who contacted the NIH regarding adverse events they experienced after receiving the COVID-19 vaccine.
On April 12, 2023, CHD sued the NIH for non-compliance by filing a Complaint for Declaratory and Injunctive Relief with the US District Court in Washington, DC. In this complaint, CHD's legal team asserts that the "NIH violated the FOIA through its failure to process this request expeditiously, failure to provide a final determination, and failure to provide any of the records to which CHD is entitled."
On June 16, 2023, the NIH filed a motion to dismiss the lawsuit. CHD responded by filing an objection on June 30th, and the NIH withdrew its motion in July.
In October 2023, the NIH agreed to produce up to 7,500 pages of documents at a rate of 300 pages per month.
As of June 18, 2025, the NIH has released more than 3,000 redacted pages in response to the original FOIA request.
© 2016 - 2025 Children's Health Defense® • All Rights Reserved
Children’s Health Defense Re-Publishing Guidelines
https://childrenshealthdefense.org/uncategorized/re-publishing-guidelines/